Clinical Trial Details
| Trial ID: | L2727 |
| Source ID: | NCT02020629 |
| Associated Drug: | Lixisenatide |
| Title: | Study on Lixisenatide and Counterregulation to Hypoglycemia |
| Acronym: | |
| Status: | COMPLETED |
| Study Results: | NO |
| Results: | |
| Conditions: | Type 2 Diabetes |
| Interventions: | DRUG: Lixisenatide |
| Outcome Measures: | Primary: Glucagon response to hypoglycemia, Hypoglycemia is induced by clamp during 30 min; glucagon levels are measured during this time frame, 30 min | Secondary: Cortisol response to hypoglycemia, Hypoglycemia is induced by a clamp during 30 min. Cortisol is measured during this time frame., 30 min|Catecholamines, Hypoglycemia is induced by a clamp during 30 min. Catecholamines are measured during this time frame., 30 min | Other: HbA1c, Change in HbA1c during six weeks treatment, 6 weeks |
| Sponsor/Collaborators: | Sponsor: Lund University |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | PHASE4 |
| Enrollment: | 18 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE |
| Start Date: | 2013-12 |
| Completion Date: | 2015-08 |
| Results First Posted: | |
| Last Update Posted: | 2015-12-15 |
| Locations: | Clinical Research Department, Malmö, 20502, Sweden |
| URL: | https://clinicaltrials.gov/show/NCT02020629 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|